HuagongsheHuagongshe Chemistry Print Report · For research reference only
4-Morpholinopiperidine → 6-[3,5-Bis(trifluoromethyl)benzyl]-5,6,7,8,9,10-hexahydro-4-(2-methylphenyl)-2-[4-(morpholine-4-yl)piperidine-1-yl]-5-oxopyrimido[4,5-b][1,5]diazocine
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | 4-Morpholinopiperidine | HCID 795724 | — |
| Reactant | 6-[3,5-Bis(trifluoromethyl)benzyl]-5,6,7,8,9,10-hexahydro-4-(2-methylphenyl)-2-(methylsulfonyl)-5-oxopyrimido[4,5-b][1,5]diazocine | HCID 22053591 | — |
| Product | 6-[3,5-Bis(trifluoromethyl)benzyl]-5,6,7,8,9,10-hexahydro-4-(2-methylphenyl)-2-[4-(morpholine-4-yl)piperidine-1-yl]-5-oxopyrimido[4,5-b][1,5]diazocine | HCID 22053593 | 87% |
Reaction Steps
In a similar manner to Example 1, 6-[3,5-bis(trifluoromethyl)benzyl]-5,6,7,8,9,10-hexahydro-4-(2-methylphenyl)-2-(methylsulfonyl)-5-oxopyrimido[4,5-b][1,5]diazocine (Compound of Reference Example 19; 85.9 mg) was reacted with 4-(morpholine-4-yl)piperidine (30.7 mg) to obtain 6-[3,5-bis(trifluoromethyl)benzyl]-5,6,7,8,9,10-hexahydro-4-(2-methylphenyl)-2-[4-(morpholine-4-yl)piperidine-1-yl]-5-oxopyrimido[4,5-b][1,5]diazocine (86.5 mg, 87%).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US07064119B2 |
| Source dataset | uspto-grants-2006_06 |
| ORD ID | ord-1d43bfd10cfa4d8c9c2c7ec5763938b9 |
| Source note | uspto-grants-2006_06 |